- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignancy in United Kingdom
Total 2650 results
-
Nottingham University Hospitals NHS TrustUniversity of Nottingham; University of Sheffield; Sheffield Teaching Hospitals...CompletedNutrition Aspect of Cancer | Stem Cell Transplant Complications | Prehabilitation | Haematological Malignancy | Nutritional and Metabolic Disease | Bone Marrow Transplant Complications | Exercise InterventionsUnited Kingdom
-
Medical Research CouncilCompletedMalignant MesotheliomaUnited Kingdom
-
NHS Greater Glasgow and ClydeRocket Medical plcUnknown
-
Virttu Biologics LimitedCompletedMalignant Pleural MesotheliomaUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknown
-
Guy's and St Thomas' NHS Foundation TrustBecton, Dickinson and CompanyUnknownPleural Effusion, MalignantUnited Kingdom
-
University College, LondonUniversity of Sheffield; Asthma + Lung UK; Mesothelioma UKRecruitingMalignant Pleural MesotheliomaUnited Kingdom
-
Oregon Health and Science UniversityRecruiting
-
Barts & The London NHS TrustCancer Research UK; UK: Barts Center for Experimental Cancer Medicine (CECM)...UnknownMalignant Pleural MesotheliomaUnited Kingdom
-
Celleron Therapeutics Ltd.UnknownColorectal Neoplasms MalignantUnited Kingdom
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCActive, not recruiting
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustCompletedA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NICAM)Mucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited Kingdom
-
Henry Ford Health SystemRecruitingMyeloid MalignancyUnited States
-
St. Jude Children's Research HospitalChildren's Hospital of Philadelphia; National Institute of Arthritis and Musculoskeletal...Active, not recruiting
-
Massachusetts General HospitalWithdrawn
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
National Cancer Institute (NCI)CompletedCancer | Childhood MalignancyUnited States
-
Sagimet Biosciences Inc.CompletedSolid Malignant TumorUnited Kingdom, United States
-
University of MichiganWithdrawnGastrointestinal MalignancyUnited States
-
John SarantopoulosNo longer availableAdvanced MalignancyUnited States
-
Guardant Health, Inc.CompletedNon-Hematologic MalignancyUnited States
-
Athanassios ArgirisUniversity of Pittsburgh; University of North Carolina, Chapel HillWithdrawnSalivary Gland MalignancyUnited States
-
SCRI Development Innovations, LLCBayerCompletedRefractory MalignancyUnited States
-
SanofiCompletedNeoplasm MalignantNetherlands, Belgium, Spain, Italy, United Kingdom
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
Papworth Hospital NHS Foundation TrustCompletedMetastatic Cancer | Malignant MesotheliomaUnited Kingdom
-
King's College LondonBayerUnknown
-
University of Alabama at BirminghamMerck Sharp & Dohme LLCCompleted
-
SCRI Development Innovations, LLCNovartisCompletedSolid Tumors | Refractory MalignancyUnited States
-
University of LeicesterEli Lilly and Company; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; British Lung Foundation and other collaboratorsActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
M.D. Anderson Cancer CenterActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | COVID-19 Infection | Recurrent Hematologic MalignancyUnited States
-
Patrick Wagner, MD, FACSList Biological Laboratories, IncRecruitingAbdominal Cancer | MalignancyUnited States
-
Wales Cancer Trials UnitPierre Fabre LaboratoriesCompleted
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics IncWithdrawn
-
Joaquina BarandaActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | Solid Tumor | Malignant Disease | Relapsed Hematologic MalignancyUnited States
-
AUSL ROMAGNAInternational Society of Geriatric Oncology; European Society of Surgical Oncology and other collaboratorsUnknownElderly | Solid MalignancyUnited States, Poland, Italy, Greece, Israel, Netherlands, Norway, Portugal, Spain, United Kingdom
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Aprea TherapeuticsCompletedMyeloid MalignancyUnited States
-
Immunocore LtdTerminated
-
Leonard ApplemanAstraZenecaCompletedAdvanced Incurable Solid MalignancyUnited States
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Malignant LymphomaUnited Kingdom, Japan
-
University College, LondonRecruitingCardiovascular Diseases | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Cardiotoxicity | Malignancy | Oesophagus Cancer | Fluorouracil Adverse ReactionUnited Kingdom
-
Scripps Translational Science InstituteCompleted
-
Incyte CorporationTerminatedSolid Tumor MalignancyUnited States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
-
Scancell LtdTerminated
-
Millennium Pharmaceuticals, Inc.Completed
-
Century Therapeutics, Inc.RecruitingHematological Malignancy | Solid Tumor MalignancyUnited States
-
Astellas Pharma Global Development, Inc.CompletedRelapsed Lymphoid Malignancy | Refractory Lymphoid MalignancyUnited States, Canada